Âå¾Ç¨¤«×¡X¡XÄÀºÃ¡G¬Ì­]·|¾É­P¦å¤pªO´î¤Ö¯g¡B¤Þ°_ÄY­«ªº¤º¥X¦å¶Ü¡H

[2021.03.02] µoªí

³¢µúÆ[Âå¥Í(Dr. Jason Kwok)

¦b¤µ´Á§Ú©M¤j®aÄ~Äò¸Ñµª¦³Ãö·s«aªÍª¢¬Ì­]ªººÃ°Ý¡C

·s«aªÍª¢¬Ì­]·|¾É­P

¦å¤pªO´î¤Ö¯g¡B¤Þ°_ÄY­«ªº¤º¥X¦å¶Ü¡H

¦³³ø¾É¿×¦³¤H¦b±µºØ¤F·s«aªÍª¢¬Ì­]«á¦]¦å¤pªO´î¤Ö¦Ó¥X²{ÄY­«ªº¤º¥X¦å¡B¥]¬A¸£·¸¦å¦Ó¦º¤`¡B¤ë¸g¶q¼W¦hµ¥¡A¥O¤H¹ï±µºØ·s«a¬Ì­]¦s¦³ºÃ¼{¡AÅý§Ú­Ì¤F¸Ñ¹ê±¡¡C

¦å¤pªO(Platelet¡B¤SºÙthrombocyte)¬O¦å²G¤º¤TºØ¦å²Ó­M¨ä¤¤¤§¤@¡A¥t¥~¨âºØ¬O¬õ¦å²y©M¥Õ¦å²y¡A¦å¤pªOÀ°§U¦å²G¾®µ²¡B¦b¨ü¶Ë®Éµo´§¤î¦åªº¥\¥Î¡C ¦å¤pªO¬O¦b°©Åè»s³yªº¡A¦b¦å²GùعB¦æ¡A¥­§¡¹Ø©R¥u±o¤K¦Ü¤Q¤Ñ¡A³Ì«á¦bµÊŦ©M¨xŦ³Q³æ®Ö§]¾½²Ó­M²M°£¡A¥¿±`ªº¦å¤pªO¼Æ¶q¬O¨C¤@·L¤É(microliter)ªº¦å²G¦³150,000¦Ü450,000¦å¤pªO¡C¦å¤pªO´î¤Ö¯g(thrombocytopenia)ªº¯gª¬¥]¬A¡G®e©ö©Î¹L¶q·ï¶Ë(ºÙ¬°µµðJ¡Bpurpura)¡B¥Ö¤U²Ó¤p¬õµµ¦âªº·ïÂI(petechiae)¡B¶Ë¤fªø®É¶¡¬y¦å¡B¬y»ó¦å©Î¤úÅi¥X¦å¡B§¿²G©ÎÁT«K¦³¦å¡B¤ë¸g¶q¦h¡B¸£·¸¦åµ¥¡C

¾É­P¦å¤pªO´î¤Ö¯gªº¯f¦]¥]¬A¡G

(¤@)´î¤Ö»s³y¦å¤pªO¡G¥]¬A¥Õ¦å¯f(leukemia)©M¨ä¥LÀù¯f¡B¬Y¨Ç³h¦å¯g¡B¯f¬r·P¬V(¨Ò¦p¨xª¢¡B·R´þ¯fµ¥)¡B¹qÀø©Î¤ÆÀø¡B¹L¶q³Ü°sµ¥¡C

(¤G)¼W¥[¦å¤pªOªº²M°£¡GÃh¥¥¡Fµß¦å¯g(bacteremia¡B¦å²G¤¤¥X²{²Óµß)¡F¬Y¨ÇÃĪ«¡G¨Ò¦p¨x¯À(Heparin)¡B«¶¹ç(quinine¡B¤SºÙª÷Âû¯ÇÁ÷)¡BÁDÓiÃþÃĪ«(Sulfonamides)¡B§Üµj¾¯(anticonvulsants)µ¥¡F·»¦å©Ê§¿¬rºî¦X¯g(Hemolytic-uremic syndrome)¡B¦å®ê©Ê¦å¤pªO?¤Ö©ÊµµðJ(Thrombotic Thrombocytopenic Purpura)µ¥¡C

¦Ü©ó±µºØ¤F·s«a¬Ì­]¦Ó¥X²{ªº¦å¤pªO´î¤Ö¯g¡AÂå¾Ç¬É»{¬°¥i¯à¬O§K¬Ì©Ê¦å¤pªO´î¤Ö¯g(Immune thrombocytopenia)¤Þ°_ªº¡A¦b¥¿±`ªº±¡ªp¤U¡A§K¬Ì¨t²Î¤£·|¹ï¦ÛÅ骺²Õ´©M²Ó­M§@¥X§ðÀ»¡A¦ý¦b¬Y¨Ç±¡ªp¤U·|¹ï¦ÛÅ骺¦å¤pªO§@¥X§ðÀ»©M¯}Ãa¡B¾É­P¦å¤pªO¼Æ¶q¤U­°¦Ó¥X²{¨Öµo¯g¡A§K¬Ì¨t²Î¥i¦]¦h­Ó¤£¦Pªº¯f¦]¦Ó¥X²{°ÝÃD¡A¥]¬A¡G(¤@)ÃĪ«¡B¬Æ¦Ü¬O¤@¨Ç¤£»ÝÂå¥Í³B¤èªºÃĪ«(over-the-counter medications¡B²ºÙOTCÃĪ«)¡F(¤G)·P¬V¡B³q±`¬O¯f¬r·P¬V¡A¨Ò¦p¤ôµk¡B¤þ«¬¨xª¢¡B·R´þ¯f¬rµ¥¡F(¤T)Ãh¥¥¡F(¥|)¦ÛÅé§K¬Ì©Ê¯e¯f(Auto-immune diseases)¡G¨Ò¦pÃþ­·Àã©ÊÃö¸`ª¢¡B¬õ´³¯T½Hµ¥¡F(¤­)²O¤Ú½F(lymphoma)©M¥Õ¦å¯f¡F(¤»)¯f¦]¤£©ú¡GºÙ¬°¯Sµo©Ê¦å¤pªO´î¤Ö©ÊµµðJ(Idiopathic Thrombocytopenic Purpura¡B²ºÙITP)¡C¦hºØ¬Ì­]·|¾É­P§K¬Ì©Ê¦å¤pªO´î¤Ö¯g¡A¥]¬A­·¯l¡B¸|¸¢ª¢©M·ò¯l²V¦X¬Ì­](²ºÙMMR)¡B¥Ò«¬¨xª¢¬Ì­]¡B¤ôµk¬Ì­]¡B¥Õ³ï¯}¶Ë­·¦Ê¤é«y²V¦X¬Ì­]¡B¬y·P¬Ì­]µ¥¡A¦ýµo¯f²v«D±`§C¡A¤£¨¬¥H¼vÅT±µºØ¬Ì­]ªº¨M©w¡C

½÷·ç©M²ö¼w¯Ç¨â¶¡»sÃĤ½¥q¬ãµoªº·s«aªÍª¢¬Ì­]©Ò°µªºÁ{§É¹êÅç¡A¤À§O¦³¥|¸U¥|¤d©M¤T¸U¦W¤H¤h°Ñ»P¸ÕÅç¡A¦bµÛ¦Wªº·s­^­ÛÂå¾Ç´Á¥Z(New England Journal of Medicine)µoªí¬ã¨s³ø§i¡AÄY­«ªº¤£¨}¨Æ¥ó(adverse events)¬O¨u¨£ªº¡A¦b±µºØ¬Ì­]©M¹ï·Ó²Õªº¤ñ¨Ò¬Û¦ü¡A¦Ó¦å¤pªO´î¤Ö¯g¨Ã¤£¦b¤£¨}¨Æ¥ó¤§¦C¡CºI¦Ü2021¦~2¤ë8¤é¡A¦b¬ü°ê±µºØ¤F¥|¤d¦h¸U¾¯·s«aªÍª¢¬Ì­]«á¡AÁp¨¹¬F©²ªº¡u¬Ì­]¤£¨}¨Æ¥ó³q³ø¨t²Î¡v(Vaccine Adverse Event Reporting System¡B²ºÙVAERS)¦@±µÀò¤T¤Q¤»­Ó¦å¤pªO´î¤Ö¯gªº³ø§i¡A®Ú¾Ú¬ü°ê­¹«~ÃĪ«ºÞ²z§½(U.S. Food and Drug Administration¡B²ºÙFDA)ªº¸ê®Æ¡A¬ü°ê¨C¦~¦b¤T¸U¤­¤d¤H¤¤´N¦³¤@¤H½T¶E±w¤W§K¬Ì©Ê¦å¤pªO´î¤Ö¯g¡A³o»P¬ü°ê¨u¨£¯e¯f²Õ´(The National Organization for Rare Disorders¡B²ºÙNORD)ªº¸ê®Æ¡B¨C¦~¨C¤Q¸U¦W¦¨¦~¤H´N¦³3.3¤H±w¤W³o­Ó¯e¯f«D±`±µªñ¡A©Ò¥H¡A³o¬O¬Ì­]ªº°Æ§@¥ÎÁÙ¬O¥©¦X¤´¦³«Ý¦³Ãö³¡ªù½T»{¡A¦Ó¦³Ãö³¡ªù·|Ä~Äò¸ò¶i¡C

Âå¾Ç±M®aªº·N¨£¬O§K¬Ì©Ê¦å¤pªO´î¤Ö¯gªº­·ÀI»·¤ñ±w¤W·s«aªÍª¢ªº­·ÀI§C¡A©Ò¥H¡A¤j²³¤£À³¥H³o­Ó­ì¦]¦Ó¤£±µºØ·s«aªÍª¢¬Ì­]¡A­Y¥»¨­±w¦³¦å¤pªO´î¤Ö¯gªº¤HÀ³¦V®a®xÂå¥Í©Î±M¬ìÂå¥Í¬d¸ß¡A¨ä¥L¥¿±`ªº¤H¦b±µºØ¬Ì­]«áÀ³¯d·N¦³¨S¦³¥X²{¦å¤pªO´î¤Öªº¯gª¬¡A­Y¥X²{¯gª¬À³ºÉ§Ö¨D¶E¡A¤Î®É©M¾A·íªºªvÀø¬O³Ì­«­nªº¡C

§ó¦h°·±dÂå¨Æ

©ú³øºô¯¸ ¡P ª©Åv©Ò¦³ ¡P ¤£±oÂà¸ü
Copyright © 2021 mingpaocanada.com All rights reserved.
Ming Pao Daily News A wholly owned subsidiary of Ming Pao Enterprise Corporation Ltd.
Toronto Chinese Newspaper

1355 Huntingwood Drive, Scarborough, Ontario, Canada M1S 3J1 | Tel.: (416) 321-0088 | Fax: (416) 321-5377 | Advertising Hotline Tel: (416) 673-8250